Testing is conducted to diagnose, understand and help prevent the spread of SARS-CoV-2/novel coronavirus. Follow our Educational Series on testing to stay abreast of the latest updates at Sutter. In Part 2 of this series, we describe antibody tests for SARS-CoV-2.
Shining Light on Mental Health: Research at Sutter Helps Reimagine the Future of Mental Health for At-risk Youth
As the novel coronavirus pandemic ushers in uncertainty that may evoke anxiety, depression or other mental health concerns for today’s youth, what would a new vision for their mental health look like? New screening tools for early detection of severe depression and suicide risk, as well as a novel program called Youth Mental Health Reimagined may be part of the path forward.
When a global health crisis began endangering communities across Northern California, Sutter research and operational staff started brainstorming new ways to track the spread of COVID-19 and launch strategies for early detection and ongoing surveillance. Learn how these data detectives are partnering to bring top-quality care to patients and communities across Sutter’s integrated network.
Paying it Forward: Sutter Teams with Vitalant to Offer COVID-19 Survivor-Donated Blood Plasma to Patients
New research suggests blood plasma collected from people who have recovered from COVID-19 may help treat patients with severe cases of the disease. Learn how Sutter’s new partnership with Vitalant will deliver this ground-breaking care to patients.
When Sutter Roseville Medical Center leadership began preparations for a potential surge of COVID-19 patients, they knew what needed to be done: Get their Emergency Department and ICU expansion finished pronto.
Stephen H. Lockhart, M.D., Sutter Health chief medical officer and executive sponsor of Sutter’s Environmental Stewardship Program, shares his thoughts on how everyone can care for our planet today and after COVID-19 passes.
Imagine a future where doctors could predict which therapies will best treat patients with cancer, personalized to a person’s specific type of the disease. That future may become a reality at Sutter, as researchers explore the potential use of artificial intelligence technology and machine learning in clinical practice.
When the Spanish flu hit Northern California, Sacramento had few options to care for its sick and dying population. So 17 local physicians decided to do something about it.
How blood, urine and gene mutations may unlock secrets to lung cancer treatment options.
More than 600 types of drugs exist to treat cancer. A new tool will help doctors supercharge their searches for the ones that will work best for their patients.